Suchergebnisse - "Arthritis, Rheumatoid"

PubPharm (246)

31

Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe : placebo-controlled double blind tapering after the GLORIA trial

enthalten in: Annals of the rheumatic diseases | 2023

von Almayali, A. | Boers, M. | Hartman, L. | +16

32

Suboptimal management of rheumatoid arthritis in France : a real-world study based on data from the French National Health Data System

enthalten in: RMD open | 2023

von Gaujoux-Viala, C. | Bergmann, J. | Goguillot, M. | +5

33

Patient and physician assessment in difficult-to-treat rheumatoid arthritis : patterns of subjective perception at early stages of b/tsDMARD treatment

enthalten in: RMD open | 2023

von Novella-Navarro, M. | Cabrera-Alarcón, J. | López-Juanes, N. | +7

34

Response to : Correspondence on "Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?" by Boers

enthalten in: Annals of the rheumatic diseases | 2023

von Studenic, P. | Aletaha, D. | Stamm, T. | +4

CommentOn: Ann Rheum Dis. 2020 Apr;79(4):445-452. - PMID 32024651

35

Correspondence on "Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis : are the current ACR/EULAR Boolean criteria optimal?"

enthalten in: Annals of the rheumatic diseases | 2023

von Boers, M.

CommentOn: Ann Rheum Dis. 2020 Apr;79(4):445-452. - PMID 32024651

36

Irreversible covalent Bruton's tyrosine kinase inhibitor, TAS5315 versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate : a randomised, double-blind, phase IIa trial

enthalten in: Annals of the rheumatic diseases | 2023

von Takeuchi, T. | Tanaka, S. | Murata, M. | +1

37

JAK inhibitors and the risk of malignancy : a meta-analysis across disease indications

enthalten in: Annals of the rheumatic diseases | 2023

von Russell, M. | Stovin, C. | Alveyn, E. | +10

38

Gender-specific differences in the diagnosis and treatment of inflammatory rheumatic diseases

enthalten in: Innere Medizin (Heidelberg, Germany) | 2023

von Albrecht, K. | Strangfeld, A.

39

Effects of filgotinib on semen parameters and sex hormones in male patients with inflammatory diseases : results from the phase 2, randomised, double-blind, placebo-controlled MANTA and MANTA-RAy studies

enthalten in: Annals of the rheumatic diseases | 2023

von Reinisch, W. | Hellstrom, W. | Dolhain, R. | +16

40

The MIDORA trial : a phase II, randomised, double-blind, placebo-controlled, mechanistic insight and dosage optimisation study of the efficacy and safety of dazodalibep in patients with rheumatoid arthritis

enthalten in: RMD open | 2023

von Kivitz, A. | Wang, L. | Alevizos, I. | +4

ErratumIn: RMD Open. 2023 Dec 19;9(4):. - PMID 38114200